These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36792048)

  • 1. NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death.
    Huang Y; Wei D; Wang B; Tang D; Cheng A; Xiao S; Yu Y; Huang W
    Acta Biomater; 2023 Apr; 160():198-210. PubMed ID: 36792048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-associated ER stress evokes immunogenic cell death through the ROS-PERK-eIF2α pathway under PTT/CDT combined therapy.
    Feng X; Lin T; Chen D; Li Z; Yang Q; Tian H; Xiao Y; Lin M; Liang M; Guo W; Zhao P; Guo Z
    Acta Biomater; 2023 Apr; 160():211-224. PubMed ID: 36792045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergizing autophagic cell death and oxaliplatin-induced immunogenic death by a self-delivery micelle for enhanced tumor immunotherapy.
    Deng T; Chen D; Chen F; Xu C; Zhang Q; Li M; Wang Y; He Z; Li M; He Q
    Acta Biomater; 2024 Dec; 190():548-559. PubMed ID: 39426655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A NIR-Light-Activated and Lysosomal-Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep-Seated Tumors.
    Li C; Tu L; Xu Y; Li M; Du J; Stang PJ; Sun Y; Sun Y
    Angew Chem Int Ed Engl; 2024 Sep; 63(37):e202406392. PubMed ID: 38775364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy.
    Zhao X; Yang K; Zhao R; Ji T; Wang X; Yang X; Zhang Y; Cheng K; Liu S; Hao J; Ren H; Leong KW; Nie G
    Biomaterials; 2016 Sep; 102():187-97. PubMed ID: 27343466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy.
    Song H; Cai Z; Li J; Xiao H; Qi R; Zheng M
    J Nanobiotechnology; 2022 Jul; 20(1):329. PubMed ID: 35842642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIR-II Light Accelerated Prodrug Reduction of Pt(IV)-Incorporating Pseudo Semiconducting Polymers for Robust Degradation and Maximized Photothermal/Chemo-Immunotherapy.
    Tang D; Zhou H; Cui M; Liang G; Zhang H; Xiao H
    Adv Mater; 2023 Jul; 35(28):e2300048. PubMed ID: 37016274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-Infrared-II Light Induced Mild Hyperthermia Activate Cisplatin-Artemisinin Nanoparticle for Enhanced Chemo/Chemodynamic Therapy and Immunotherapy.
    Xiong G; Huang D; Lu L; Luo X; Wang Y; Liu S; Chen M; Yu S; Kappen M; You C; Lu S; Yu Y; Lu J; Lin F
    Small Methods; 2022 Sep; 6(9):e2200379. PubMed ID: 35978419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Oxaliplatin Prodrug Nanoparticles for Second Near-Infrared Fluorescence Imaging-Guided Immunotherapy of Colorectal Cancer.
    Zhu Q; Sun F; Li T; Zhou M; Ye J; Ji A; Wang H; Ding C; Chen H; Xu Z; Yu H
    Small; 2021 Apr; 17(13):e2007882. PubMed ID: 33690984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer.
    Huang Y; Guan Z; Dai X; Shen Y; Wei Q; Ren L; Jiang J; Xiao Z; Jiang Y; Liu D; Huang Z; Xu X; Luo Y; Zhao C
    Nat Commun; 2021 Jul; 12(1):4310. PubMed ID: 34262026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles integrated with mild photothermal therapy and oxaliplatin for tumor chemotherapy and immunotherapy.
    Yi Q; He S; Liao K; Yue Z; Mei L
    Nanomedicine (Lond); 2024 Apr; 19(10):841-854. PubMed ID: 38436253
    [No Abstract]   [Full Text] [Related]  

  • 13. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
    Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
    Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-Infrared II Phototherapy Induces Deep Tissue Immunogenic Cell Death and Potentiates Cancer Immunotherapy.
    Ma Y; Zhang Y; Li X; Zhao Y; Li M; Jiang W; Tang X; Dou J; Lu L; Wang F; Wang Y
    ACS Nano; 2019 Oct; 13(10):11967-11980. PubMed ID: 31553168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-Infrared Light-Enhanced Generation of Hydroxyl Radical for Cancer Immunotherapy.
    Zhang Q; Li Y; Jiang C; Sun W; Tao J; Lu L
    Adv Healthc Mater; 2023 Nov; 12(28):e2301502. PubMed ID: 37409492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
    Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
    Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation.
    Luo S; Yang Y; Chen L; Kannan PR; Yang W; Zhang Y; Zhao R; Liu X; Li Y; Kong X
    Acta Biomater; 2024 Jun; 181():402-414. PubMed ID: 38734282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor-Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer Immunotherapy.
    Huang C; Lin B; Chen C; Wang H; Lin X; Liu J; Ren Q; Tao J; Zhao P; Xu Y
    Adv Mater; 2022 Dec; 34(51):e2207593. PubMed ID: 36245299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction.
    Roberts NB; Alqazzaz A; Hwang JR; Qi X; Keegan AD; Kim AJ; Winkles JA; Woodworth GF
    J Neurooncol; 2018 Dec; 140(3):497-507. PubMed ID: 30132163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Pt(IV) prodrug self-assembled nanoparticles with enhanced blood circulation stability and improved antitumor capacity of oxaliplatin for cancer therapy.
    Fu Y; Kong Y; Li X; Cheng D; Hou Y; Li Y; Li T; Xiao Y; Zhang Q; Rong R
    Drug Deliv; 2023 Dec; 30(1):2171158. PubMed ID: 36744299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.